Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New immunosuppressive agents].

G Socié1, E Thervet

  • 1Service d'Hématologie Greffe de Moelle, Hôpital Saint-Louis, Paris.

Pathologie-Biologie
|November 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Severe corneal manifestations of graft-versus-host disease: Experience of a tertiary referral center.

The ocular surface·2024
Same author

Specificities of Meningitis and Meningo-Encephalitis After Kidney Transplantation: A French Retrospective Cohort Study.

Transplant international : official journal of the European Society for Organ Transplantation·2023
Same author

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.

Bone marrow transplantation·2021
Same author

Acute kidney injury after valacyclovir administration for prevention of congenital cytomegalovirus infection.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.

Scandinavian journal of rheumatology·2021
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

New immunosuppressive drugs offer targeted approaches to prevent transplant rejection and treat autoimmune diseases. Further research will refine their clinical applications and optimize combination therapies for improved safety and efficacy.

Area of Science:

  • Immunology
  • Pharmacology

Context:

  • Advances in understanding transplant rejection mechanisms have driven the development of novel immunosuppressive agents.
  • These agents selectively target specific immune response pathways.

Purpose:

  • To review emerging immunosuppressive drugs and their potential applications in transplantation and autoimmune disorders.
  • To highlight the mechanisms of action and clinical utility of agents like Neoral, Tacrolimus, Rapamycin, RAD, and Mycophenolate mofetil.

Summary:

  • Neoral (cyclosporin microemulsion) offers improved absorption over conventional forms.
  • Tacrolimus inhibits calcineurin, similar to cyclosporin.
  • Rapamycin and RAD target cytokine signaling to T-cells; Mycophenolate mofetil inhibits purine synthesis and lymphocyte proliferation, showing efficacy in autoimmune disorders.

Related Experiment Videos

Impact:

  • These new drugs hold promise for treating autoimmune diseases and graft-versus-host disease.
  • Further clinical investigation is crucial to establish definitive therapeutic indications.
  • Understanding their mechanisms may lead to optimized drug combinations for enhanced efficacy and safety in immunosuppression.